DayTwo logo

DayTwo Funding & Investors

Walnut Creek, CA

DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. The DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and to communicate with members. DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.

daytwo.com

Total Amount Raised:

DayTwo Funding Rounds

  • Series B

    26,300,000 GBP

    Series B Investors

    Cathay Innovation
    Micron Ventures
    La Maison Partners
    Jacky Abitbol
    Yair Schindel
    Poalim Equity
    AMOON VENTURES Y.SH.
    Volta Circle
    10D
  • Series B

    $5,000,000

    Series B Investors

    Cathay Innovation
    Longliv Ventures
    Samsung Next
  • Series B

    $31,000,000

    Series B Investors

    Cathay Innovation
    Omri Casspi
    Johnson & Johnson
    Seventure Partners
    Longliv Ventures
    AMOON VENTURES Y.SH.
    Samsung Next
    10D
  • Series A

    $12,000,000

    Series A Investors

    Marius Nacht
    Johnson & Johnson
    Seventure Partners
    Mayo Clinic
    French Investment Fund
    Century Partners
  • Seed

    $5,000,000

Funding info provided by Diffbot.